AdAlta（1AD）株式概要臨床段階のバイオテクノロジー企業であるAdAlta Limitedは、オーストラリアでi-bodyプラットフォームによるタンパク質および細胞ベースの治療薬の発見と開発を行っている。 詳細1AD ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6報酬過去5年間の収益は年間2.5%増加しました。 リスク分析Australian市場と比較して、過去 3 か月間の株価の変動が非常に大きい意味のある時価総額がありません ( A$12M )マイナスの株主資本 過去1年間で株主の希薄化は大幅に進んだ +1 さらなるリスクすべてのリスクチェックを見る1AD Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW490,690 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG490,690 investors already sharing narrativesYour Fair ValueAU$Current PriceAU$0.0039.9k% 割高 内在価値ディスカウントEst. Revenue$PastFuture-8m4m2016201920222025202620282031Revenue AU$110.2kEarnings AU$20.1kAdvancedSet Fair ValueView all narrativesAdAlta Limited 競合他社Cambium BioSymbol: ASX:CMBMarket cap: AU$11.1mNoxopharmSymbol: ASX:NOXMarket cap: AU$28.0mImugeneSymbol: ASX:IMUMarket cap: AU$43.7mHeximaSymbol: ASX:HXLMarket cap: AU$2.2m価格と性能株価の高値、安値、推移の概要AdAlta過去の株価現在の株価AU$0.00352週高値AU$0.007552週安値AU$0.002ベータ0.191ヶ月の変化-14.29%3ヶ月変化-14.29%1年変化20.00%3年間の変化-88.46%5年間の変化-97.78%IPOからの変化-98.42%最新ニュースお知らせ • Jun 09AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 106,312,738 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Transaction Features: Subsequent Direct ListingBoard Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Michelle Burke was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 04+ 1 more updateAdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 2.5 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 2.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 106,312,738 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 518,687,262 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Jan 13AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 240,000,000 Price\Range: AUD 0.005 Discount Per Security: AUD 0.0003 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Oct 20AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 366,666,667 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00018 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Oct 13+ 1 more updateAdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.5 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 153,657,204 Price\Range: AUD 0.003 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,009,463 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing最新情報をもっと見るRecent updatesお知らせ • Jun 09AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 106,312,738 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Transaction Features: Subsequent Direct ListingBoard Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Michelle Burke was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 04+ 1 more updateAdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 2.5 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 2.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 106,312,738 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 518,687,262 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Jan 13AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 240,000,000 Price\Range: AUD 0.005 Discount Per Security: AUD 0.0003 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Oct 20AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 366,666,667 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00018 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Oct 13+ 1 more updateAdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.5 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 153,657,204 Price\Range: AUD 0.003 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,009,463 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Sep 24AdAlta Limited, Annual General Meeting, Nov 19, 2025AdAlta Limited, Annual General Meeting, Nov 19, 2025. Location: piper alderman, level 23, 459 collins street, melbourne vic 3000, and, AustraliaNew Risk • Aug 28New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.9m free cash flow). Share price has been highly volatile over the past 3 months (35% average weekly change). Negative equity (-AU$598k). Shareholders have been substantially diluted in the past year (94% increase in shares outstanding). Revenue is less than US$1m (AU$696k revenue, or US$454k). Market cap is less than US$10m (AU$4.62m market cap, or US$3.01m).Board Change • Aug 18No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Michelle Burke was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Jun 30Adalta Limited Announces Resignation of Iain Ross as Non-Executive Director, Effective Date Is June 30, 2025AdAlta Limited announced that non-executive director, Iain Ross, has tendered his resignation effective from 30 June 2025 due to the potential for conflicts of interest to emerge between AdAlta and another company he serves.お知らせ • May 01AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.286446 million.AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.286446 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 317,148,667 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00003 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 100,000,000 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00018 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 11,666,667 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00003 Transaction Features: Rights OfferingBoard Change • Dec 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Iain Ross was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 23AdAlta Limited Appoints Kevin Lynch as Consultant Chief Medical Officer of AdCellaAdAlta Limited announced a significant addition to its AdCella leadership team. Kevin Lynch MB BS has been appointed as Consultant Chief Medical Officer. In this role he will help support the selection of in-licensed cellular immunotherapies and the design and execution of Phase I clinical trials by AdCella. Consultant CMO-AdCella, Kevin Lynch MB BS, based in Australia with leading industry and China haematology/oncology experience. Dr. Lynch has taken on the role of Consultant CMO-AdCella, as this AdAlta subsidiary continues to execute its East to West cellular immunotherapy strategy. Dr. Lynch is a highly experienced industry physician. His 30 years' experience span all stages of clinical development, regulatory and reimbursement approvals and post-registration medical activities. He has contributed to multiple transformational therapies in haematology/oncology at both early- to late-stage therapies, including imatinib, nilotinib, lenalidomide and pomalidomide. He has led high level regulatory interactions in Australia (including for cell therapies), China, South Korea, Singapore, Europe, and other markets. Importantly, he has also provided senior input into multiple interactions with the US Food & Drug Administration (FDA). Dr. Lynch is Co-Founder of PopulusBio srl. His previous leadership roles include CMO at Antengene and senior medical and clinical roles at Celgene and Novartis.お知らせ • Oct 18AdAlta Limited, Annual General Meeting, Nov 20, 2024AdAlta Limited, Annual General Meeting, Nov 20, 2024. Location: at piper alderman, level 23, 459 collins stree, melbourne, 3000, AustraliaNew Risk • Jun 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m). Market cap is less than US$100m (AU$16.1m market cap, or US$10.7m).New Risk • Feb 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (67% increase in shares outstanding). Market cap is less than US$10m (AU$9.99m market cap, or US$6.54m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m).お知らせ • Dec 20AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.66 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.66 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 60,000,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,000,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0.0012 Transaction Features: Subsequent Direct Listingお知らせ • Dec 19AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.46 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.46 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,000,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0.0012 Transaction Features: Subsequent Direct ListingNew Risk • Nov 15New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$5.1m free cash flow). Earnings have declined by 0.5% per year over the past 5 years. Market cap is less than US$10m (AU$8.41m market cap, or US$5.49m). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Shareholders have been diluted in the past year (41% increase in shares outstanding). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m).お知らせ • Nov 03AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.23 million.AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.23 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 61,500,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0 Transaction Features: Subsequent Direct Listingお知らせ • Sep 22AdAlta Limited, Annual General Meeting, Nov 22, 2023AdAlta Limited, Annual General Meeting, Nov 22, 2023, at 11:01 AUS Eastern Standard Time. Location: Piper Alderman, Level 23, 459 Collins Street Melbourne Victoria Australia Agenda: To provide business update to Shareholders.New Risk • Aug 26New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$5.1m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 0.5% per year over the past 5 years. Market cap is less than US$10m (AU$10.2m market cap, or US$6.51m). Minor Risks Shareholders have been diluted in the past year (41% increase in shares outstanding). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m).お知らせ • Jul 13AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 3.153759 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 3.153759 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 51,303,619 Price\Range: AUD 0.025 Discount Per Security: AUD 0.0015 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 74,846,752 Price\Range: AUD 0.025 Discount Per Security: AUD 0.0015 Security Features: Attached Options Transaction Features: Rights OfferingBoard Change • Mar 09Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 03First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.015 loss in 1H 2022)First half 2023 results: AU$0.009 loss per share (improved from AU$0.015 loss in 1H 2022). Revenue: AU$1.11m (up 53% from 1H 2022). Net loss: AU$2.82m (loss narrowed 23% from 1H 2022).Board Change • Feb 21Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jan 10Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Nov 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Oct 05Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 30Full year 2022 earnings released: AU$0.022 loss per share (vs AU$0.024 loss in FY 2021)Full year 2022 results: AU$0.022 loss per share. Revenue: AU$2.76m (down 31% from FY 2021). Net loss: AU$6.06m (loss widened 7.7% from FY 2021).Board Change • Aug 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 28Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 29Full year 2021 earnings released: AU$0.024 loss per share (vs AU$0.037 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: AU$3.99m (up 4.2% from FY 2020). Net loss: AU$5.63m (loss narrowed 6.3% from FY 2020).Reported Earnings • Mar 03First half 2021 earnings released: AU$0.021 loss per share (vs AU$0.037 loss in 1H 2020)The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: AU$806.5k (up 100% from 1H 2020). Net loss: AU$4.51m (loss narrowed 25% from 1H 2020).株主還元1ADAU BiotechsAU 市場7D-25.0%0.8%-0.4%1Y20.0%-45.1%2.0%株主還元を見る業界別リターン: 1AD過去 1 年間で-45.1 % の収益を上げたAustralian Biotechs業界を上回りました。リターン対市場: 1AD過去 1 年間で2 % の収益を上げたAustralian市場を上回りました。価格変動Is 1AD's price volatile compared to industry and market?1AD volatility1AD Average Weekly Movement28.8%Biotechs Industry Average Movement10.4%Market Average Movement9.5%10% most volatile stocks in AU Market16.7%10% least volatile stocks in AU Market3.9%安定した株価: 1ADの株価は、 Australian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 1ADの weekly volatility ( 29% ) は過去 1 年間安定していますが、依然としてAustralianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20061Tim Oldhamwww.adalta.com.au臨床段階のバイオテクノロジー企業であるAdAlta Limitedは、オーストラリアでi-bodyプラットフォームによるタンパク質および細胞ベースの治療薬の発見と開発を行っている。主力製品はAD-214で、特発性肺線維症、眼線維症、肝臓・皮膚・腎臓の線維症、加齢黄斑変性などの線維症治療薬として第II相臨床試験中である。アダルタ・リミテッドは、免疫腫瘍学で使用されるi-body対応PETイメージング剤を開発するためにGEヘルスケア・テクノロジー社と、固形腫瘍のCAR-T細胞療法を開発するためにカリーナ・バイオテック社と共同パートナーシップを結んでいる。同社は2006年に法人化され、オーストラリアのキャンバーウェルに拠点を置いている。もっと見るAdAlta Limited 基礎のまとめAdAlta の収益と売上を時価総額と比較するとどうか。1AD 基礎統計学時価総額AU$11.90m収益（TTM）-AU$4.36m売上高(TTM)AU$608.07k19.6xP/Sレシオ-2.7xPER（株価収益率1AD は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計1AD 損益計算書（TTM）収益AU$608.07k売上原価AU$219.37k売上総利益AU$388.71kその他の費用AU$4.75m収益-AU$4.36m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.0015グロス・マージン63.92%純利益率-717.51%有利子負債／自己資本比率0%1AD の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/10 21:05終値2026/07/09 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋AdAlta Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Maxim JacobsEdison Investment ResearchScott PowerMorgans Financial LimitedDerek JellinekMorgans Financial Limited
お知らせ • Jun 09AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 106,312,738 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
Board Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Michelle Burke was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 04+ 1 more updateAdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 2.5 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 2.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 106,312,738 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 518,687,262 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Jan 13AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 240,000,000 Price\Range: AUD 0.005 Discount Per Security: AUD 0.0003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Oct 20AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 366,666,667 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00018 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Oct 13+ 1 more updateAdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.5 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 153,657,204 Price\Range: AUD 0.003 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,009,463 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Jun 09AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 106,312,738 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
Board Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Michelle Burke was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 04+ 1 more updateAdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 2.5 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 2.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 106,312,738 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 518,687,262 Price\Range: AUD 0.004 Discount Per Security: AUD 0.00024 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Jan 13AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 240,000,000 Price\Range: AUD 0.005 Discount Per Security: AUD 0.0003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Oct 20AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 366,666,667 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00018 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Oct 13+ 1 more updateAdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.5 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 153,657,204 Price\Range: AUD 0.003 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,009,463 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Sep 24AdAlta Limited, Annual General Meeting, Nov 19, 2025AdAlta Limited, Annual General Meeting, Nov 19, 2025. Location: piper alderman, level 23, 459 collins street, melbourne vic 3000, and, Australia
New Risk • Aug 28New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.9m free cash flow). Share price has been highly volatile over the past 3 months (35% average weekly change). Negative equity (-AU$598k). Shareholders have been substantially diluted in the past year (94% increase in shares outstanding). Revenue is less than US$1m (AU$696k revenue, or US$454k). Market cap is less than US$10m (AU$4.62m market cap, or US$3.01m).
Board Change • Aug 18No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Michelle Burke was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 30Adalta Limited Announces Resignation of Iain Ross as Non-Executive Director, Effective Date Is June 30, 2025AdAlta Limited announced that non-executive director, Iain Ross, has tendered his resignation effective from 30 June 2025 due to the potential for conflicts of interest to emerge between AdAlta and another company he serves.
お知らせ • May 01AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.286446 million.AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.286446 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 317,148,667 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00003 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 100,000,000 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00018 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 11,666,667 Price\Range: AUD 0.003 Discount Per Security: AUD 0.00003 Transaction Features: Rights Offering
Board Change • Dec 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Iain Ross was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 23AdAlta Limited Appoints Kevin Lynch as Consultant Chief Medical Officer of AdCellaAdAlta Limited announced a significant addition to its AdCella leadership team. Kevin Lynch MB BS has been appointed as Consultant Chief Medical Officer. In this role he will help support the selection of in-licensed cellular immunotherapies and the design and execution of Phase I clinical trials by AdCella. Consultant CMO-AdCella, Kevin Lynch MB BS, based in Australia with leading industry and China haematology/oncology experience. Dr. Lynch has taken on the role of Consultant CMO-AdCella, as this AdAlta subsidiary continues to execute its East to West cellular immunotherapy strategy. Dr. Lynch is a highly experienced industry physician. His 30 years' experience span all stages of clinical development, regulatory and reimbursement approvals and post-registration medical activities. He has contributed to multiple transformational therapies in haematology/oncology at both early- to late-stage therapies, including imatinib, nilotinib, lenalidomide and pomalidomide. He has led high level regulatory interactions in Australia (including for cell therapies), China, South Korea, Singapore, Europe, and other markets. Importantly, he has also provided senior input into multiple interactions with the US Food & Drug Administration (FDA). Dr. Lynch is Co-Founder of PopulusBio srl. His previous leadership roles include CMO at Antengene and senior medical and clinical roles at Celgene and Novartis.
お知らせ • Oct 18AdAlta Limited, Annual General Meeting, Nov 20, 2024AdAlta Limited, Annual General Meeting, Nov 20, 2024. Location: at piper alderman, level 23, 459 collins stree, melbourne, 3000, Australia
New Risk • Jun 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m). Market cap is less than US$100m (AU$16.1m market cap, or US$10.7m).
New Risk • Feb 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (67% increase in shares outstanding). Market cap is less than US$10m (AU$9.99m market cap, or US$6.54m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m).
お知らせ • Dec 20AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.66 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.66 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 60,000,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,000,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0.0012 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 19AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.46 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.46 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,000,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0.0012 Transaction Features: Subsequent Direct Listing
New Risk • Nov 15New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$5.1m free cash flow). Earnings have declined by 0.5% per year over the past 5 years. Market cap is less than US$10m (AU$8.41m market cap, or US$5.49m). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Shareholders have been diluted in the past year (41% increase in shares outstanding). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m).
お知らせ • Nov 03AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.23 million.AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.23 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 61,500,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0 Transaction Features: Subsequent Direct Listing
お知らせ • Sep 22AdAlta Limited, Annual General Meeting, Nov 22, 2023AdAlta Limited, Annual General Meeting, Nov 22, 2023, at 11:01 AUS Eastern Standard Time. Location: Piper Alderman, Level 23, 459 Collins Street Melbourne Victoria Australia Agenda: To provide business update to Shareholders.
New Risk • Aug 26New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$5.1m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 0.5% per year over the past 5 years. Market cap is less than US$10m (AU$10.2m market cap, or US$6.51m). Minor Risks Shareholders have been diluted in the past year (41% increase in shares outstanding). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m).
お知らせ • Jul 13AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 3.153759 million.AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 3.153759 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 51,303,619 Price\Range: AUD 0.025 Discount Per Security: AUD 0.0015 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 74,846,752 Price\Range: AUD 0.025 Discount Per Security: AUD 0.0015 Security Features: Attached Options Transaction Features: Rights Offering
Board Change • Mar 09Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 03First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.015 loss in 1H 2022)First half 2023 results: AU$0.009 loss per share (improved from AU$0.015 loss in 1H 2022). Revenue: AU$1.11m (up 53% from 1H 2022). Net loss: AU$2.82m (loss narrowed 23% from 1H 2022).
Board Change • Feb 21Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jan 10Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Nov 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Oct 05Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 30Full year 2022 earnings released: AU$0.022 loss per share (vs AU$0.024 loss in FY 2021)Full year 2022 results: AU$0.022 loss per share. Revenue: AU$2.76m (down 31% from FY 2021). Net loss: AU$6.06m (loss widened 7.7% from FY 2021).
Board Change • Aug 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 28Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 29Full year 2021 earnings released: AU$0.024 loss per share (vs AU$0.037 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: AU$3.99m (up 4.2% from FY 2020). Net loss: AU$5.63m (loss narrowed 6.3% from FY 2020).
Reported Earnings • Mar 03First half 2021 earnings released: AU$0.021 loss per share (vs AU$0.037 loss in 1H 2020)The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: AU$806.5k (up 100% from 1H 2020). Net loss: AU$4.51m (loss narrowed 25% from 1H 2020).
